BioStock Investor Meeting: Elicera Therapeutics presents

Gothenburg-based Elicera Therapeutics, headed by CEO Jamal El-Mosleh, travelled to Stockholm to present the company at the BioStock Investor Meeting. Elicera Therapeutics is a cell and gene therapy company with a fully developed technology platform called iTANK (ImmunoTherapies Activated with NAP for efficient Killing) to be used to fight cancer. 

See the presentation at biostock.se:

https://www.biostock.se/en/2022/09/biostock-investor-meeting-elicera-therapeutics-presents/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/